Bacteroides thetaiotaomicron-derived outer membrane vesicles promote regulatory dendritic cell responses in health but not in inflammatory bowel disease.


Journal

Microbiome
ISSN: 2049-2618
Titre abrégé: Microbiome
Pays: England
ID NLM: 101615147

Informations de publication

Date de publication:
08 06 2020
Historique:
received: 17 12 2019
accepted: 13 05 2020
entrez: 10 6 2020
pubmed: 10 6 2020
medline: 2 3 2021
Statut: epublish

Résumé

Bacteroides thetaiotaomicron (Bt) is a prominent member of the human intestinal microbiota that, like all gram-negative bacteria, naturally generates nanosized outer membrane vesicles (OMVs) which bud off from the cell surface. Importantly, OMVs can cross the intestinal epithelial barrier to mediate microbe-host cell crosstalk involving both epithelial and immune cells to help maintain intestinal homeostasis. Here, we have examined the interaction between Bt OMVs and blood or colonic mucosa-derived dendritic cells (DC) from healthy individuals and patients with Crohn's disease (CD) or ulcerative colitis (UC). In healthy individuals, Bt OMVs stimulated significant (p < 0.05) IL-10 expression by colonic DC, whereas in peripheral blood-derived DC they also stimulated significant (p < 0.001 and p < 0.01, respectively) expression of IL-6 and the activation marker CD80. Conversely, in UC Bt OMVs were unable to elicit IL-10 expression by colonic DC. There were also reduced numbers of CD103 Overall, our findings suggest a key role for OMVs generated by the commensal gut bacterium Bt in directing a balanced immune response to constituents of the microbiota locally and systemically during health which is altered in IBD patients. Video Abstract.

Sections du résumé

BACKGROUND
Bacteroides thetaiotaomicron (Bt) is a prominent member of the human intestinal microbiota that, like all gram-negative bacteria, naturally generates nanosized outer membrane vesicles (OMVs) which bud off from the cell surface. Importantly, OMVs can cross the intestinal epithelial barrier to mediate microbe-host cell crosstalk involving both epithelial and immune cells to help maintain intestinal homeostasis. Here, we have examined the interaction between Bt OMVs and blood or colonic mucosa-derived dendritic cells (DC) from healthy individuals and patients with Crohn's disease (CD) or ulcerative colitis (UC).
RESULTS
In healthy individuals, Bt OMVs stimulated significant (p < 0.05) IL-10 expression by colonic DC, whereas in peripheral blood-derived DC they also stimulated significant (p < 0.001 and p < 0.01, respectively) expression of IL-6 and the activation marker CD80. Conversely, in UC Bt OMVs were unable to elicit IL-10 expression by colonic DC. There were also reduced numbers of CD103
CONCLUSIONS
Overall, our findings suggest a key role for OMVs generated by the commensal gut bacterium Bt in directing a balanced immune response to constituents of the microbiota locally and systemically during health which is altered in IBD patients. Video Abstract.

Identifiants

pubmed: 32513301
doi: 10.1186/s40168-020-00868-z
pii: 10.1186/s40168-020-00868-z
pmc: PMC7282036
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

88

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L004291/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/J004529/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R012490/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/F/000PR10353
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/F/000PR10356
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L01632X/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/F/000PR10355
Pays : United Kingdom

Références

Biochem Soc Trans. 2018 Oct 19;46(5):1021-1027
pubmed: 30154095
mBio. 2018 Mar 13;9(2):
pubmed: 29535205
Nat Immunol. 2014 Jan;15(1):98-108
pubmed: 24292363
J Exp Med. 2020 Jan 6;217(1):
pubmed: 31611251
mBio. 2014 Mar 11;5(2):e00909-14
pubmed: 24618254
Cell Mol Gastroenterol Hepatol. 2015 Sep 03;2(1):22-39.e5
pubmed: 26866054
J Exp Med. 1991 Nov 1;174(5):1209-20
pubmed: 1940799
Sci Rep. 2016 Apr 27;6:24866
pubmed: 27117743
Inflamm Bowel Dis. 2018 Mar 19;24(4):792-805
pubmed: 29529198
Inflamm Bowel Dis. 2014 Dec;20(12):2299-307
pubmed: 25397892
Nature. 2012 Jun 13;486(7402):207-14
pubmed: 22699609
Exp Biol Med (Maywood). 2012 May;237(5):540-7
pubmed: 22569032
Immunology. 2015 Feb;144(2):333-42
pubmed: 25179236
Clin Exp Immunol. 2019 Jun;196(3):287-304
pubmed: 30985006
Appl Microbiol. 1974 May;27(5):961-79
pubmed: 4598229
Cell Microbiol. 2009 Mar;11(3):521-30
pubmed: 19134113
Best Pract Res Clin Gastroenterol. 2004 Apr;18(2):255-70
pubmed: 15123068
Inflamm Bowel Dis. 2019 May 4;25(6):e71
pubmed: 30561647
Immunity. 2014 May 15;40(5):720-33
pubmed: 24792913
PeerJ. 2015 Jul 28;3:e1061
pubmed: 26246963
Mol Nutr Food Res. 2014 May;58(5):1132-43
pubmed: 24347371
J Pathol. 1999 Jun;188(2):220-6
pubmed: 10398168
Cell Host Microbe. 2015 May 13;17(5):672-80
pubmed: 25974305
Science. 2003 Mar 28;299(5615):2074-6
pubmed: 12663928
Cell Host Microbe. 2012 Oct 18;12(4):509-20
pubmed: 22999859
Eur J Immunol. 2012 May;42(5):1337-53
pubmed: 22539302
Cold Spring Harb Perspect Biol. 2014 Sep 04;6(10):a016295
pubmed: 25190079
Nat Immunol. 2004 Jan;5(1):104-12
pubmed: 14691478
Immunology. 2017 Aug;151(4):363-374
pubmed: 28542929
Gastroenterology. 2017 Nov;153(5):1320-1337.e16
pubmed: 28782508
Immunol Lett. 2013 Feb;150(1-2):30-40
pubmed: 23352670
J Exp Med. 1998 Feb 16;187(4):571-8
pubmed: 9463407
J Exp Med. 2007 Aug 6;204(8):1775-85
pubmed: 17620362
Am J Gastroenterol. 2011 Aug;106(8):1544-55
pubmed: 21519361
Eur J Immunol. 1997 May;27(5):1229-35
pubmed: 9174615
Vaccine. 2005 Mar 18;23(17-18):2191-6
pubmed: 15755593
Mucosal Immunol. 2016 Jan;9(1):171-82
pubmed: 26080709
Microbiology. 2015 Mar;161(Pt 3):565-79
pubmed: 25533445
Science. 2001 Feb 2;291(5505):881-4
pubmed: 11157169
BMC Biol. 2013 May 21;11:61
pubmed: 23692866
Biochem J. 2017 May 16;474(11):1823-1836
pubmed: 28512250
N Engl J Med. 2009 Nov 19;361(21):2033-45
pubmed: 19890111
Inflamm Bowel Dis. 2019 Jan 1;25(1):85-96
pubmed: 30215718
Front Microbiol. 2017 Dec 08;8:2440
pubmed: 29276507
Front Microbiol. 2020 Feb 06;11:57
pubmed: 32117106
J Exp Med. 1973 Nov 1;138(5):1156-67
pubmed: 4200775
J Crohns Colitis. 2020 May 21;14(4):525-537
pubmed: 31665283
Cell. 1993 Oct 22;75(2):263-74
pubmed: 8402911
J Immunol. 1991 Dec 1;147(11):3815-22
pubmed: 1940369
Mediators Inflamm. 2013;2013:573576
pubmed: 23970814
Semin Immunol. 2014 Feb;26(1):75-9
pubmed: 24447345
Nat Rev Gastroenterol Hepatol. 2017 Oct;14(10):573-584
pubmed: 28743984
Microbiome. 2018 Apr 20;6(1):73
pubmed: 29678198
PLoS Biol. 2016 Aug 19;14(8):e1002533
pubmed: 27541692
Gut. 2016 Feb;65(2):256-70
pubmed: 25666191
J Exp Med. 1975 Feb 1;141(2):297-305
pubmed: 803544
Autoimmun Rev. 2014 Jan;13(1):3-10
pubmed: 23774107
Inflamm Bowel Dis. 2011 May;17(5):1201-8
pubmed: 21484962
Immunity. 2014 May 15;40(5):706-19
pubmed: 24792912
Immunity. 2011 Apr 22;34(4):554-65
pubmed: 21511184
J Exp Med. 2007 Aug 6;204(8):1757-64
pubmed: 17620361
Inflamm Bowel Dis. 2013 Dec;19(13):2820-8
pubmed: 24216686
J Extracell Vesicles. 2019 Jun 24;8(1):1632100
pubmed: 31275534
Cancer Immunol Res. 2014 Apr;2(4):288-94
pubmed: 24764575
Cell Rep. 2014 Feb 27;6(4):646-56
pubmed: 24529702
Lancet. 2018 Dec 23;390(10114):2769-2778
pubmed: 29050646
Oncotarget. 2016 May 31;7(22):32015-30
pubmed: 27027442
J Antimicrob Chemother. 2015 Mar;70(3):701-9
pubmed: 25433011
Science. 2005 Jun 10;308(5728):1635-8
pubmed: 15831718
Mucosal Immunol. 2019 Sep;12(5):1201-1211
pubmed: 31417161
Biotechnol Adv. 2017 Sep;35(5):565-574
pubmed: 28522212
Gastroenterology. 2011 Aug;141(2):653-62, 662.e1-4
pubmed: 21679711
Am J Clin Nutr. 1972 Dec;25(12):1292-4
pubmed: 4639749
Nat Rev Immunol. 2015 Jun;15(6):375-87
pubmed: 25976515
Cell Host Microbe. 2011 May 19;9(5):390-403
pubmed: 21575910
J Gen Microbiol. 1967 Oct;49(1):1-11
pubmed: 4168882
J Exp Med. 2016 Apr 4;213(4):517-34
pubmed: 27001748

Auteurs

Lydia Durant (L)

Antigen Presentation Research Group, Imperial College London, Northwick Park & St. Mark's Hospital Campus, Watford Rd, Harrow, Greater London, HA1 3UJ, UK. l.durant@imperial.ac.uk.

Régis Stentz (R)

Gut Microbes and Health Research Programme, Quadram Institute Bioscience, Norwich, NR4 7UQ, UK.

Alistair Noble (A)

Antigen Presentation Research Group, Imperial College London, Northwick Park & St. Mark's Hospital Campus, Watford Rd, Harrow, Greater London, HA1 3UJ, UK.

Johanne Brooks (J)

Gut Microbes and Health Research Programme, Quadram Institute Bioscience, Norwich, NR4 7UQ, UK.
Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK.

Nadezhda Gicheva (N)

Gut Microbes and Health Research Programme, Quadram Institute Bioscience, Norwich, NR4 7UQ, UK.

Durga Reddi (D)

Antigen Presentation Research Group, Imperial College London, Northwick Park & St. Mark's Hospital Campus, Watford Rd, Harrow, Greater London, HA1 3UJ, UK.

Matthew J O'Connor (MJ)

Antigen Presentation Research Group, Imperial College London, Northwick Park & St. Mark's Hospital Campus, Watford Rd, Harrow, Greater London, HA1 3UJ, UK.

Lesley Hoyles (L)

Department of Biosciences, Nottingham Trent University, Clifton Campus, Nottingham, NG11 8NS, UK.

Anne L McCartney (AL)

Food Microbial Sciences Unit, University of Reading, Whiteknights, Reading, RG6 6UR, UK.

Ripple Man (R)

St Mark's Hospital, London North West University Healthcare NHS Trust, Harrow, Greater London, HA1 3UJ, UK.

E Tobias Pring (ET)

Antigen Presentation Research Group, Imperial College London, Northwick Park & St. Mark's Hospital Campus, Watford Rd, Harrow, Greater London, HA1 3UJ, UK.
St Mark's Hospital, London North West University Healthcare NHS Trust, Harrow, Greater London, HA1 3UJ, UK.

Stella Dilke (S)

Antigen Presentation Research Group, Imperial College London, Northwick Park & St. Mark's Hospital Campus, Watford Rd, Harrow, Greater London, HA1 3UJ, UK.
St Mark's Hospital, London North West University Healthcare NHS Trust, Harrow, Greater London, HA1 3UJ, UK.

Philip Hendy (P)

Antigen Presentation Research Group, Imperial College London, Northwick Park & St. Mark's Hospital Campus, Watford Rd, Harrow, Greater London, HA1 3UJ, UK.
St Mark's Hospital, London North West University Healthcare NHS Trust, Harrow, Greater London, HA1 3UJ, UK.

Jonathan P Segal (JP)

St Mark's Hospital, London North West University Healthcare NHS Trust, Harrow, Greater London, HA1 3UJ, UK.

Dennis N F Lim (DNF)

St Mark's Hospital, London North West University Healthcare NHS Trust, Harrow, Greater London, HA1 3UJ, UK.

Ravi Misra (R)

St Mark's Hospital, London North West University Healthcare NHS Trust, Harrow, Greater London, HA1 3UJ, UK.

Ailsa L Hart (AL)

St Mark's Hospital, London North West University Healthcare NHS Trust, Harrow, Greater London, HA1 3UJ, UK.

Naila Arebi (N)

St Mark's Hospital, London North West University Healthcare NHS Trust, Harrow, Greater London, HA1 3UJ, UK.

Simon R Carding (SR)

Gut Microbes and Health Research Programme, Quadram Institute Bioscience, Norwich, NR4 7UQ, UK.
Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK.

Stella C Knight (SC)

Antigen Presentation Research Group, Imperial College London, Northwick Park & St. Mark's Hospital Campus, Watford Rd, Harrow, Greater London, HA1 3UJ, UK.
St Mark's Hospital, London North West University Healthcare NHS Trust, Harrow, Greater London, HA1 3UJ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH